THE CRASH-3 RESULTS ARE IN!
12737 Patients randomised
1811 Total number of patients randomised in the Golden hour to date
Recruitment closed on the 31 January 2019, well done. Thanks so much for all your hard work!!!
WATCH
Every minute counts
SUBSCRIBE
Receive the trial results
LATEST BLOG POSTS
CRASH-3 timeline to publication!
Prof Ian Roberts shares the timeline for CRASH-3 trial data collection, site closure and the publication!...
CONGRATULATIONS from the team at Miri Hospital, Malaysia
WE MADE IT!! Congratulations from the team at Miri Hospital, Malaysia. With the trial outcome due this summer, we are so excited share the results of all our collaborators' hard work!!...
RESOURCES FOR COLLABORATORS
12,737 patients recruited
29 recruiting countries
175 hospitals and medical centres
ABOUT THE TRIAL
The CRASH-3 trial aims to provide the research based information to prevent death by Traumatic Brain Injury.
The CRASH-3 trial is testing whether tranexamic acid, a blood clot stabiliser that was discovered in Japan in the 1950’s, can become an essential tool for fighting excessive bleeding in the brain after Traumatic Brain Injury.
more infoPATIENT INFORMATION
If you were a patient randomised into this trial and would like further information about your treatment, click below.
The staff at the hospital where you were being treated for your traumatic brain injury should have given you an information leaflet about the CRASH3 trial. If you have any questions or concerns about your treatment in the hospital, please contact your doctor in the first instance.
more info